NeuroSense Presents PrimeC Clinical and Biomarker Findings at NEALS Meeting
NeuroSense presented clinical and biomarker findings for PrimeC at the NEALS Annual Meeting.
Related stories
Invesco Mortgage Capital Swings to Q3 Net Loss of $95.64 Million
Invesco Mortgage Capital reported a Q3 2026 net loss of $95.64 million, compared with a profit a year earlier.
M impact | EQUITY | Oct 29, 2026, 08:59 PM UTC
Coinbase Q3 Revenue Falls 35% to $1.22 Billion, Profit Beats Estimates
Coinbase reported Q3 2026 revenue of $1.22 billion, down 35% year over year, while GAAP profit was $2.51 per share, above analysts’ consensus estimates.
M impact | EQUITY | Oct 29, 2026, 08:59 PM UTC
Monolithic Power Q3 Revenue and Adjusted EPS Beat Estimates
Monolithic Power's third-quarter revenue rose 63% year over year.
M impact | EQUITY | Oct 29, 2026, 08:57 PM UTC
Digital Realty Trust Q3 Profit Rises to $185.165 Million
Digital Realty Trust reported third-quarter earnings of $185.165 million, or $0.48 per share, compared with $57.631 million, or $0.15 per share, a year earlier.
M impact | EQUITY | Oct 29, 2026, 08:57 PM UTC
Arthur J. Gallagher Reports Third-Quarter 2026 Earnings Growth
Net income and revenue both increased in the third quarter of 2026.
M impact | EQUITY | Oct 29, 2026, 08:57 PM UTC
PennyMac Financial Agrees to Sell $29 Billion in Conventional MSRs
PennyMac Financial Services agreed after quarter-end to sell $29 billion in unpaid principal balance of low-rate conventional mortgage servicing rights.
M impact | EQUITY | Oct 29, 2026, 08:52 PM UTC